Ftse Mib
38.154,91
1,21%
DAX
22.641,77
1,46%
S&P 500
5.599,69
0,50%
NASDAQ
17.631,40
1,12%
Bitcoin
82.622,32
-0,27%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BioCardia Inc (BCDA) BioCardia Inc (BCDA) Notizie

BioCardia Inc

BCDA
2,55
-0,02 (-0,78%)
Ultimo aggiornamento: 14:57:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/3/202514:15EDGAR2Form 8-K - Current report
10/3/202514:15GLOBEBioCardia Announces Japanese Patent for Helix™..
07/3/202514:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202514:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202514:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202515:15EDGAR2Form 8-K - Current report
27/2/202515:15GLOBEBioCardia Announces Primary Outcome Measures Data Freeze in..
13/2/202514:30EDGAR2Form 8-K - Current report
13/2/202514:30GLOBEBioCardia Reports Completion of Low Dose Cohort Enrollment..
12/2/202514:00EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
31/1/202502:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202515:15EDGAR2Form 8-K - Current report
27/1/202515:15GLOBEBioCardia Announces Late Breaking Clinical Trial..
26/12/202420:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202420:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202417:50EDGAR2Form 144 - Report of proposed sale of securities
17/12/202413:00EDGAR2Form 8-K - Current report
17/12/202413:00GLOBEBioCardia Announces Commercial Availability of Morph® DNA™..
09/12/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202414:30EDGAR2Form 8-K - Current report
04/12/202414:30GLOBEBioCardia Announces Positive Consultation with Japan PMDA on..
02/12/202423:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/11/202414:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202422:05GLOBEBioCardia Reports Third Quarter 2024 Business Highlights and..
06/11/202413:00GLOBEBioCardia to Host Q3 2024 Corporate Update and Financial..
28/10/202414:00EDGAR2Form 8-K - Current report
28/10/202414:00GLOBEBioCardia Completes Phase III Randomized Double-Blind..
17/10/202403:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202414:30EDGAR2Form 8-K - Current report
18/9/202414:30GLOBEBioCardia Regains Full Compliance with Nasdaq Listing..
09/9/202422:06EDGAR2Form 8-K - Current report
09/9/202422:05GLOBEBioCardia Announces Closing of Upsized $7.2 Million Public..
07/9/202401:45EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
05/9/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202418:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202412:01EDGAR2Form 8-K - Current report
30/8/202423:21EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/8/202423:20EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/8/202414:00EDGAR2Form 8-K - Current report
30/8/202414:00GLOBEBioCardia Announces Pricing of Upsized $7.2 Million Public..
Apertura: 2,56 Min: 2,55 Max: 2,71
Chiusura: 2,57

La tua Cronologia

NASDAQ
BCDA
BioCardia
BIT
P1U605
BNP Paribas Issuance
NASDAQ
FDZCX
Bmo North American Divid...
BIT
F35324
Vontobel Financial Produ...
BIT
F34624
Vontobel Financial Produ...
BIT
S29082
Societe Generale Effekten
BIT
F28183
Vontobel Financial Produ...
NASDAQ
KRNT
Kornit Digital
AQSE
3WHL.GB
WisdomTree Commodity Sec...
BIT
1PNE
PNE
CSE
BAMM
Body and Mind
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci